Senti Biosciences Inc. (NASDAQ: SNTI) Stock Information | RedChip

Senti Biosciences Inc. (NASDAQ: SNTI) Listen to this Section


$2.34
+0.0450 ( +1.97% ) 25.1K

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

Market Data


Open


$2.34

Previous close


$2.29

Volume


25.1K

Market cap


$10.57M

Day range


$2.27 - $2.39

52 week range


$1.52 - $8.48

Insider Ownership Transactions

Total Amount Purchased: -758,000.00 | $ -1,769,930.00

Date Type Amount Purchased Purchaser
2024-07-12 Sale -62500.00 Mathers Edward T
2024-07-12 Sale -62500.00 COOPERSTONE BRENDA
2024-07-12 Sale -62500.00 Collins James J.
2024-07-12 Sale -62500.00 Farokhzad Omid
2024-02-02 Sale -101000.00 KNOBELMAN DEBORAH
2024-02-02 Sale -306000.00 Lu Timothy K
2024-02-02 Sale -101000.00 Rajangam Kanya

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Aug 13, 2024
10-q Quarterly Reports 84 Aug 13, 2024
8-k 8K-related 15 Jul 17, 2024
8-k 8K-related 14 Jul 16, 2024
4 Insider transactions 1 Jul 12, 2024
4 Insider transactions 1 Jul 12, 2024
8-k 8K-related 14 Jul 12, 2024
4 Insider transactions 2 Jul 12, 2024
4 Insider transactions 1 Jul 12, 2024
ars Annual reports 1 May 29, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.